CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma.
Amit NairNicola IngramEldo T VergheseImeshi WijetungaAlexander F MarkhamJudy WyattK Rajendra PrasadP Louise ColettaPublished in: Cellular oncology (Dordrecht) (2020)
Our results indicate that CD105 is a biomarker eminently suitable for cholangiocarcinoma targeting using functionalised microbubbles.
Keyphrases